Today I read your inaugural issue of Genome Technology. Just great. Congratulation to the whole team! I cannot remember when I last read a journal from A to Z, but it''s a damned long time ago. Here I did, and I found it informative, motivating, with a good degree of novelty and content. It makes me eager to see and read the next issue. Unnecessary to say that LION will subscribe.
Friedrich von Bohlen, CEO, Lion Bioscience